Report Summary

The Company, a biopharmaceutical company engages in the development of monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection.

These PEREGRINE PHARMACEUTICALS company profiles provided detailed financial data and key credit information. PEREGRINE PHARMACEUTICALS predominantly operates in the In Vitro And In Vivo Diagnostic Substances sector. The Company, a biopharmaceutical company engages in the development of monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection.

There are five types of reports available, immediately after purchase. In order to purchase a report, please select a report type from the dropdown list above and Add to Cart. You will be able to download report(s) purchased in PDF format from your Customer Area (you need to be logged in to view) and the links are valid for 14 days. Please remember to save the PDF to your computer.

PEREGRINE PHARMACEUTICALS Quickview Report - A snapshot containing company description, key financial data items and ratios. The report provides a quick company overview for three years, presented in a one page standard company report. Data is presented in local currency and in a standardised GAAP format for easy comparison.

PEREGRINE PHARMACEUTICALS Trader Report - A trading document with concise and objective company information in a consistent format, designed to answer basic trading needs. This report covers six years of financial information and includes shares information, major shareholders, income statement and balance sheet data in addition to key financial ratios.

PEREGRINE PHARMACEUTICALS Dossier Report - Gives you 10 years of financial history up to 150 lines of numerical data, including analytic ratios presented in a five page standard company report. Substantial supplementary information including subsidiaries, directors, major shareholders as well as business and geographical breakdown is also covered.

PEREGRINE PHARMACEUTICALS Business Risk Report - A one-page standard business risk measurement report. The report provides peer-to-peer comparisons of business risk factor analyses including operating, strategic, asset, size & diversity, overall adjustment and industry standard deviation.

PEREGRINE PHARMACEUTICALS Credit Risk Report - Provides an analysis of a company's creditworthiness and debt capacity including a rating and a number of standard ratios analysis & model results. The report includes an analysis of a company's creditworthiness and debt capacity by using a methodology based on well-established academic research. It provides peer-to-peer comparisons of credit risk factors analyses including credit rating, other standard credit scoring measurements, non-financial information, subsidiaries, major shareholders, profitability, interest coverage, capitalization and debt service capacity, liquidity, balance sheet and income statement.